- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
In the August 2017 issue, the story “Breaking through: How researchers are gaining entry into barricaded bacteria” (_Nat. Med._ 23, 907–910, 2017) misstated that the pharmaceutical company
Achaogen would be filing a New Drug Application with the FDA in 2018. The company will be filing an Investigational New Drug application. The article was also unclear in wording the progress
of siderophore-conjugated antibiotics. Such antibiotics have made it to clinical trials, but none so far have made it to market. The errors have been corrected in the HTML and PDF versions
of the article as of 23 August 2017. ADDITIONAL INFORMATION The online version of the original article can be found at 10.1038/nm0817-907 RIGHTS AND PERMISSIONS Reprints and permissions
ABOUT THIS ARTICLE CITE THIS ARTICLE Correction. _Nat Med_ 23, 1011 (2017). https://doi.org/10.1038/nm0917-1011 Download citation * Published: 01 September 2017 * Issue Date: 01 September
2017 * DOI: https://doi.org/10.1038/nm0917-1011 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is
not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative
